MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease.
Nath SR, Lieberman ML, Yu Z, Marchioretti C, Jones ST, Danby ECE, Van Pelt KM, Sorarù G, Robins DM, Bates GP, Pennuto M, Lieberman AP.
Nath SR, et al. Among authors: jones st.
Acta Neuropathol. 2020 Jul;140(1):63-80. doi: 10.1007/s00401-020-02156-4. Epub 2020 Apr 18.
Acta Neuropathol. 2020.
PMID: 32306066
Free PMC article.